TRxADE HEALTH, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Surendra K. Ajjarapu
- Full Time Employees
- 8
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 3840 Land O’ Lakes Boulevard Land O'Lakes FL United States of America 34639
- IPO Date
- Feb 6, 2014
- CIK
- 0001382574
- Website
- trxadehealth.com
- Similar Companies
- Business
- TRxADE HEALTH, Inc. (NASDAQ: MEDS) operates an online pharmaceutical marketplace that connects independent pharmacies with pharmaceutical distributors, manufacturers, and other suppliers across the United States. The company provides a suite of digital services and products, including its proprietary TRxADE platform for real-time pricing, inventory management, and order fulfillment; Tru-Pak for drop-shipping and packaging services; and TRxADE Prime, a subscription-based analytics tool offering market intelligence, competitive bidding, and supply chain optimization for independent pharmacies. Founded in 2018 and headquartered in Boca Raton, Florida, TRxADE HEALTH focuses on serving independent retail pharmacies, wholesalers, and healthcare providers in the U.S. pharmaceutical distribution sector, with no international operations publicly noted. In recent developments within the last year, the company has pursued strategic expansions in its digital health offerings, including enhancements to its AI-driven procurement tools and partnerships aimed at improving drug pricing transparency amid ongoing supply chain challenges. No major acquisitions, funding rounds, or rebranding have been announced as of late 2025.
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership Team
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
TRxADE Health, Inc. Announces Special Cash Dividend
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
TRxADE Health, Inc. Announces Special Cash Dividend
Why Is Trxade Health (MEDS) Stock Up 230% Today?
Trxade health, Inc files its 3Q 10Q
TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q.
TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023.
Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales
Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry.
TRxADE Health (NASDAQ:MEDS), Newly Merged With Superlatus, Is Gearing Up To Make Big Splashes In the $151 Billion Snacks Industry with its Acquisition of The Urgent Company Inc.
TRxADE Health (NASDAQ:MEDS), Newly Merged With Superlatus, To Acquire The Urgent Company to Expand its Reach In The Sustainable Foods Market
Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand
Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.
TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
Newly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management Team